RA CAPITAL MANAGEMENT, L.P. purchased 23.3% of their position (223.60K shares) of ADICET BIO, INC. on the open market
Open‑market purchase worth $1.60M — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 4/13/2026ACC: 0001231919-26-000337
10% Owner
Since Feb 2026
+223.60K
Net shares
Net buyer
$1.60M
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
223.60K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+74.58K
Price / share
$7.04
Trade value
$525.02K
% of position
7.8%
2/18/2026
959.03K→1.03M
Common Stock
Indirect
Shares
+74.27K
Price / share
$7.21
Trade value
$535.47K
% of position
7.2%
2/19/2026
1.03M→1.11M
Common Stock
Indirect
Shares
+74.75K
Price / share
$7.27
Trade value
$543.44K
% of position
6.7%
2/20/2026
1.11M→1.18M
Total
Net shares
+223.60K
Net value
$1.60M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/18/2026 | P · Purchase | +74.58K | $7.04 | $525.02K | 7.8% | 959.03K | 1.03M |
| Common Stock Indirect | 2/19/2026 | P · Purchase | +74.27K | $7.21 | $535.47K | 7.2% | 1.03M | 1.11M |
| Common Stock Indirect | 2/20/2026 | P · Purchase | +74.75K | $7.27 | $543.44K | 6.7% | 1.11M | 1.18M |
| Total | +223.60K | $1.60M | ||||||
Derivative Transactions0
No derivative transactions reported